BBCR, LLC offers to biopharmaceutical companies a specialized clinical strategy service that includes:
- Medical support to early-stage companies, hands-on medical services including IND clinical strategies, trial design, medical representative to regulatory meetings and medical monitoring
- Innovative strategies and clinical development plans (roadmaps) for a successful and cost-effective drug development
- Optimization of clinical strategies and milestone establishment to meet challenging limited financial resources with a value added approach
- Early identification of critical gaps in the clinical development process and implementation to reduce unbudgeted costs and time to market
- Special attention to the patients’ safety, risk-benefit assessment and risk management
Today’s biotech challenges require innovative solutions. BBCR leads the way introducing the Strategic Clinical Innovation Concept.
CUSTOMIZE: One size fits all clinical strategy/design model cannot address your product qualities and potentials. We tailor the clinical development strategy to your product to optimize properties and potentials.
INTEGRATE: Clinical development and trial design must integrate regulatory requirements and market needs. Our goals are to link pre-clinical data to market opportunities, and design clinical trials connecting product potentials to treatment benefits.
INNOVATE : The challenges of our time require a strategic approach to build the drugs and devices of the future. Our broad knowledge and long-term experience allow us to provide our customers with capital-efficient, evidence-based trial design, and design-focused clinical development.
STREAMLINE : Rising costs and high competition in patient recruitment force companies to carefully evaluate trial design and redundancies. We create cohesive first in man/POC studies that match development questions with study results. BBCR solution can save up to 25% of clinical development cost and time.